IL22 and colorectal carcinoma: However, as in IBD and CRC, the effects of ILC3 and IL-22 on the outcome of GVHD are likely to be contextual and contrasting studies have demonstrated a role for donor-derived IL-22 in exacerbating inflammation and tissue damage in GVHD [127].